The first Icosavax trade was made in Q3 2021.
Since then Ken Griffin bought shares four more times and sold shares on five occasions. The investor completely sold their stake between Q3 2023 and Q1 2024.
Avg closing price
Price range
Sold -276 Thousand shares
Q1 2024
Avg closing price
$15.44
Price range
$15.20
-
$15.88
Sold 82.8% shares (-1.33 Million shares)
Q4 2023
Avg closing price
$9.63
Price range
$5.95
-
$15.79
Sold 26.6% shares (-582 Thousand shares)
Q3 2023
Avg closing price
$8.29
Price range
$7.22
-
$10.05
Increased shares by 39.4% (+617 Thousand shares)
Q2 2023
Avg closing price
$8.00
Price range
$4.89
-
$10.57
Sold 0.2% shares (-2.82 Thousand shares)
Q1 2023
Avg closing price
$8.64
Price range
$5.62
-
$11.51
Sold 7.3% shares (-123 Thousand shares)
Q4 2022
Avg closing price
$4.29
Price range
$2.32
-
$10.97
Increased shares by 8.0% (+126 Thousand shares)
Q3 2022
Avg closing price
$6.26
Price range
$3.09
-
$9.21
Increased shares by 5.7% (+84.3 Thousand shares)
Q2 2022
Avg closing price
$7.80
Price range
$5.70
-
$10.33
Increased shares by 22.7% (+275 Thousand shares)
Q1 2022